Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.
Parisio L, Settanni CR, Varca S, Laterza L, Lopetuso LR, Napolitano D, Schiavoni E, Turchini L, Fanali C, Alfieri N, Pizzoferrato M, Papa A, Pafundi PC, Armuzzi A, Gasbarrini A, Pugliese D, Scaldaferri F. Parisio L, et al. Among authors: schiavoni e. J Gastrointestin Liver Dis. 2023 Dec 22;32(4):452-459. doi: 10.15403/jgld-5084. J Gastrointestin Liver Dis. 2023. PMID: 38147610 Free article.
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis.
Scaldaferri F, Pecere S, Petito V, Zambrano D, Fiore L, Lopetuso LR, Schiavoni E, Bruno G, Gerardi V, Laterza L, Pizzoferrato M, Ianiro G, Stojanovic J, Poscia A, Papa A, Paroni Sterbini F, Sanguinetti M, Masucci L, Cammarota G, Gasbarrini A. Scaldaferri F, et al. Among authors: schiavoni e. Transplant Proc. 2016 Mar;48(2):402-7. doi: 10.1016/j.transproceed.2015.12.040. Transplant Proc. 2016. PMID: 27109966 Review.
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR, Petito V, Graziani C, Schiavoni E, Paroni Sterbini F, Poscia A, Gaetani E, Franceschi F, Cammarota G, Sanguinetti M, Masucci L, Scaldaferri F, Gasbarrini A. Lopetuso LR, et al. Among authors: schiavoni e. Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7. Dig Dis. 2018. PMID: 28683448
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease.
Milovanovic S, Scaldaferri F, Canarecci S, Kheiraoui F, Ciancarella G, de Waure C, Collamati A, Schiavoni E, Gasbarrini A, Boccia S, Poscia A. Milovanovic S, et al. Among authors: schiavoni e. Dig Liver Dis. 2017 Oct;49(10):1098-1103. doi: 10.1016/j.dld.2017.06.015. Epub 2017 Jul 5. Dig Liver Dis. 2017. PMID: 28778820
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center.
Pizzoferrato M, de Sire R, Ingravalle F, Mentella MC, Petito V, Martone AM, Landi F, Miggiano GAD, Mele MC, Lopetuso LR, Schiavoni E, Napolitano D, Turchini L, Poscia A, Nicolotti N, Papa A, Armuzzi A, Scaldaferri F, Gasbarrini A. Pizzoferrato M, et al. Among authors: schiavoni e. Nutrients. 2019 Sep 24;11(10):2281. doi: 10.3390/nu11102281. Nutrients. 2019. PMID: 31554166 Free PMC article.
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A. Scaldaferri F, et al. Among authors: schiavoni e. United European Gastroenterol J. 2020 Aug;8(7):775-781. doi: 10.1177/2050640620929133. Epub 2020 May 21. United European Gastroenterol J. 2020. PMID: 32438878 Free PMC article.
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period.
Scaldaferri F, Papa A, Napolitano D, Rizzatti G, Pistone MT, Poscia A, Volpe M, Lopetuso LR, Schiavoni E, Guidi L, Gaetani E, Holleran G, Cammarota G, Rapaccini G, Pugliese D, Ojetti V, Franceschi F, Armuzzi A, Gasbarrini A. Scaldaferri F, et al. Among authors: schiavoni e. Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5826-5835. doi: 10.26355/eurrev_202109_26801. Eur Rev Med Pharmacol Sci. 2021. PMID: 34604974 Free article.
30 results